Nanopore and Big Data: Difference between revisions
From Federal Burro of Information
Jump to navigationJump to search
No edit summary |
No edit summary |
||
| Line 23: | Line 23: | ||
* | * | ||
'''Oportunity'' | '''Oportunity''' | ||
* | * | ||
| Line 29: | Line 29: | ||
* canada does lots of genetic research. | * canada does lots of genetic research. | ||
'''Threat''' | |||
* quagmired. | |||
* long lead times | |||
* poor margin | |||
* incumbent owns vertical | |||
* | |||
Home work: | Home work: | ||
Revision as of 03:02, 22 April 2015
Thesis: We should get into the nanopore market.
who are the players ( Nanopore manufactures )
- Oxford Nanopore Technologies https://nanoporetech.com/
- Illumina , was in an agreement with nanopore and that's been broken off. they are going to do their own thing ( http://www.illumina.com/ )
Stregnth
- Big data mating
- Margins?
- Sales cycle?
- Training?
- Maintanace / Manged place
- CLoud offering
Weakness
- long lead times , long sales cycles.
- specialized knowledge
Oportunity
- canada does lots of genetic research.
Threat
- quagmired.
- long lead times
- poor margin
- incumbent owns vertical
Home work:
- who ar the clients?
- how long are lead times?
- what do margins look like?
- is there a managed play?
- studio cloud like dedicated DC?
